Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Organoids market size was valued at USD 79.35 million in 2022 and is expected to expand at a CAGR of 17.47% during the forecast period, reaching USD 208.55 million by 2028.
Organoids are 3D miniature tissues or organs that are grown in vitro (outside the body) from stem cells or progenitor cells. These organoids can recapitulate key features of their in vivo counterparts and can be used to study the development, function, and disease mechanisms of various organs. The use of organoids has become an important tool for researchers to study human biology and disease and may provide a foundation for developing more effective treatments for various illnesses.
Increased need for disease modeling
The outbreak of COVID-19 has led to an increased demand for the use of organoids for disease modeling. Researchers have been using organoids to study viruses and their effects on different organs, such as the lungs and intestines. This has led to increased interest in organoid research and development and increased funding for this field of research. For example, during the COVID-19 pandemic, researchers demonstrated the value of human organoids, including intestinal, kidney, and lung organoids, as useful research platforms against SARSCoV-2. These results reflect the positive impact of the enormous investment in organoid-related R&D. A research team at Kyoto University in Japan has successfully created in vitro microbronchial tubes that allow air to enter the alveoli from human iPSCs, a model used to evaluate Avigan against Fujifilm Holdings Corporation's influenza drug and several novel drugs for the treatment of COVID-19. Antiviral drugs.
Increased Interest in Personalized Medicine
Organoids are an important tool for understanding viral pathology, which has prompted researchers to use organoids to develop strategies for the prediction of the COVID-19 situation and its resolution. The COVID-19 outbreak has highlighted the importance of personalized medicine, as different patients can respond very differently to the virus. Organoids are invaluable tools for personalized medicine because they can be derived from patient samples and used to test the efficacy of drugs on an individual basis. This has led to increased interest in organoid research and development for personalized medicine applications.
Technological advancements in organoid research
Technological advancement is one of the significant factors driving the growth of the organoids market. With the continuous development of organoid research technology, more and more diseases can be treated by using organoids for research and drug screening. In terms of efficiency and accuracy, the researchers were able to more accurately simulate human organs and tissues. This means better modeling of disease states during research, leading to improved treatment outcomes. Technological advances are also helping to reduce the cost of producing and maintaining organoids. This means that more organizations and institutions can use this technology for research and treatment. As the market size increases, further cost reduction will also accelerate the market development. Many rare diseases currently have no effective treatments. But as organoid technology improves, researchers will be able to better study these diseases and develop new treatments. This will drive the growth of the market as more and more people will use organoid technology to treat complex diseases. Therefore, through continuous research and innovation, the potential of this market will be continuously released, providing assistance for the treatment of more diseases.
Region Overview:
In 2022, the share of the Organoids market in United States stood at 34.12%.
Company Overview:
StemCell Technologies Inc. of Canada operates as a biotechnology company. The Company specializes in developing cell culture media, cell separation products, instruments, and other reagents for use in stem cell, immunology, cancer, regenerative medicine and cellular therapy research.
Segmentation Overview:
Among different product types, Intestinal Organoid segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Biopharmaceutical Companies segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Organoids industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Organoids. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Organoids Market Report Include:
Market Size Estimates: Organoids market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Organoids market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Organoids market
Segment Market Analysis: Organoids market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Organoids market situations and prospects in major and top regions and countries
Organoids Market
Organoids Industry Chain: Organoids market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Organoids Industry News, Policies by regions
Organoids Industry Porters Five Forces Analysis
Key players in the global Organoids market are covered in Chapter 2:
Hubrecht Organoid Technology (HUB)
SUN bioscience
DefiniGEN
Epistem
STEMCELL Technologies
Prellis Biologics
Cellesce
Crown Bioscience
In Chapter 6 and Chapter 9, on the basis of types, the Organoids market from 2018 to 2028 is primarily split into:
Intestinal Organoid
Neural Organoid
Hepatic Organoid
Pancreatic Organoid
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Organoids market from 2018 to 2028 covers:
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Organoids market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Organoids industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Organoids market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Organoids industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Organoids market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Organoids market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Organoids market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Organoids are 3D miniature tissues or organs that are grown in vitro (outside the body) from stem cells or progenitor cells. These organoids can recapitulate key features of their in vivo counterparts and can be used to study the development, function, and disease mechanisms of various organs. The use of organoids has become an important tool for researchers to study human biology and disease and may provide a foundation for developing more effective treatments for various illnesses.
Increased need for disease modeling
The outbreak of COVID-19 has led to an increased demand for the use of organoids for disease modeling. Researchers have been using organoids to study viruses and their effects on different organs, such as the lungs and intestines. This has led to increased interest in organoid research and development and increased funding for this field of research. For example, during the COVID-19 pandemic, researchers demonstrated the value of human organoids, including intestinal, kidney, and lung organoids, as useful research platforms against SARSCoV-2. These results reflect the positive impact of the enormous investment in organoid-related R&D. A research team at Kyoto University in Japan has successfully created in vitro microbronchial tubes that allow air to enter the alveoli from human iPSCs, a model used to evaluate Avigan against Fujifilm Holdings Corporation's influenza drug and several novel drugs for the treatment of COVID-19. Antiviral drugs.
Increased Interest in Personalized Medicine
Organoids are an important tool for understanding viral pathology, which has prompted researchers to use organoids to develop strategies for the prediction of the COVID-19 situation and its resolution. The COVID-19 outbreak has highlighted the importance of personalized medicine, as different patients can respond very differently to the virus. Organoids are invaluable tools for personalized medicine because they can be derived from patient samples and used to test the efficacy of drugs on an individual basis. This has led to increased interest in organoid research and development for personalized medicine applications.
Technological advancements in organoid research
Technological advancement is one of the significant factors driving the growth of the organoids market. With the continuous development of organoid research technology, more and more diseases can be treated by using organoids for research and drug screening. In terms of efficiency and accuracy, the researchers were able to more accurately simulate human organs and tissues. This means better modeling of disease states during research, leading to improved treatment outcomes. Technological advances are also helping to reduce the cost of producing and maintaining organoids. This means that more organizations and institutions can use this technology for research and treatment. As the market size increases, further cost reduction will also accelerate the market development. Many rare diseases currently have no effective treatments. But as organoid technology improves, researchers will be able to better study these diseases and develop new treatments. This will drive the growth of the market as more and more people will use organoid technology to treat complex diseases. Therefore, through continuous research and innovation, the potential of this market will be continuously released, providing assistance for the treatment of more diseases.
Region Overview:
In 2022, the share of the Organoids market in United States stood at 34.12%.
Company Overview:
StemCell Technologies Inc. of Canada operates as a biotechnology company. The Company specializes in developing cell culture media, cell separation products, instruments, and other reagents for use in stem cell, immunology, cancer, regenerative medicine and cellular therapy research.
Segmentation Overview:
Among different product types, Intestinal Organoid segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Biopharmaceutical Companies segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Organoids industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Organoids. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Organoids Market Report Include:
Market Size Estimates: Organoids market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Organoids market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Organoids market
Segment Market Analysis: Organoids market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Organoids market situations and prospects in major and top regions and countries
Organoids Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Organoids Industry Chain: Organoids market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Organoids Industry News, Policies by regions
Organoids Industry Porters Five Forces Analysis
Key players in the global Organoids market are covered in Chapter 2:
Hubrecht Organoid Technology (HUB)
SUN bioscience
DefiniGEN
Epistem
STEMCELL Technologies
Prellis Biologics
Cellesce
Crown Bioscience
In Chapter 6 and Chapter 9, on the basis of types, the Organoids market from 2018 to 2028 is primarily split into:
Intestinal Organoid
Neural Organoid
Hepatic Organoid
Pancreatic Organoid
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Organoids market from 2018 to 2028 covers:
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Organoids market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Organoids industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Organoids market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Organoids industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Organoids market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Organoids market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Organoids market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
